NOTICE IS HEREBY GIVEN that the 40th Annual General Meeting of the Members of ADS Diagnostic Limited will be held on Monday, the 29th September, 2025, at 11:30 A.M. Through Video Conferencing ....
Awaiting price reaction for this filing.
ADS Diagnostic Limited has filed its Annual Report for FY 2024-25 along with the Notice of its 40th Annual General Meeting, scheduled for Monday, 29th September 2025 at 11:30 AM via video conferencing. Operating income fell to ₹1,613.12 lakh from ₹2,405.91 lakh in the previous year, a drop of about 33%. Net profit after tax declined sharply to ₹80.50 lakh from ₹185.00 lakh, down roughly 56%. The board has recommended a dividend of ₹1.00 per share (10%) on the equity capital of ₹21.93 lakh. Dr. Gautam Sehgal has been re-appointed as Managing Director for another five years (till May 2030) with a higher monthly salary of ₹5.11 lakh plus HRA and a 20% annual increment. Promoters continue to hold 45.39% of equity, and shareholders can vote electronically with 22nd September 2025 as the cut-off date.
Revenue and profits have weakened significantly year-on-year, but the company remains profitable and is rewarding shareholders with a 10% dividend, which may support the stock. Continuity in leadership with a pay hike for the MD signals stability, though weak financials could limit upside in the near term.